Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria...
Pharmaceutical
NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury...
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a...
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
EDETEK Recognized as the highest Major Contender in Everest Group’s 2024 Clinical Data and Analytics Platforms PEAK Matrix® Assessment
PRINCETON, N.J., Nov. 13, 2024 /PRNewswire/ -- EDETEK, Inc., a leading global provider of specialized software and services for the...
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial...
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue...
Inc. Names Arbor Scientia Group as a 2024 Power Partner Award Winner
Award won after analysis of pharmaceutical clients' feedback received by Inc. regarding Arbor Scientia Group's valuable strategic partnerships and tactical support ...
TileDB Powers Multiomics Research: Now Trusted by Half of Top Global Pharma Giants
Multimodal Data Management Company Strengthens Leadership with New Board Members and Executive Appointments CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- TileDB,...
Petauri™ Acquires Formulary Insights™ in Market Access Expansion
Rapidly growing pharmaceutical services platform bolsters pricing and market access offering, merging business with Petauri Advisors NASHVILLE, Tenn., Nov. 13,...
Subtle Medical Unveils Subtle-ELITE and New Strategic Partnerships at RSNA 2024
Subtle's Latest Solutions and Partnerships Set New Benchmarks for AI-powered Acceleration and Image Quality MENLO PARK, Calif., Nov. 13, 2024...
C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov....
Ethics Board Approval Granted for Lexaria’s 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp....
Jaguar Health Reports Third Quarter 2024 Financial Results
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately...
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types
CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited...
PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
myTomorrows Appoints Vanessa Lemarié as Chief Operating Officer
Previously COO at leading health technology company Ada Health, Lemarié is an award-winning strategist whose expertise will further myTomorrows' mission...
Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Thermal Interface Materials Market to Grow by USD 3.16 Billion (2024-2028), Driven by Rising Demand in Computer Hardware, AI-Powered Report Explores Market Evolution – Technavio
NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global thermal interface materials...